chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Feb2021 as dose 1, single (Lot number: EL9262), in left arm, on 23Feb2021 as dose 2, single (Lot number: EN6200), in left arm, on 18Aug2021 as dose 3 (booster), single (Lot number: FC3181), in left arm, on 03Jan2022 as dose 4 (booster), single (Lot number: FK9729), in left arm and on 06Jun2022 as dose 5 (booster), single (Lot number: FM7653) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Psoriasis" (unspecified if ongoing), notes: Other medical history: Psoriasis and Psoriatic Arthritis; "Psoriatic Arthritis" (unspecified if ongoing), notes: Other medical history: Psoriasis and Psoriatic Arthritis. Concomitant medication(s) included: METHOTREXATE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19 included PF-07321332, ritonavir (PAXLOVID) with treatment start date 17Jun2022 and stop date 22Jun2022.
Myocarditis symptoms, pain around my heart especially when lying down in bed. Fatigue, soreness in upper left chest and underarm
some pain in the arm after the 1st vaccine; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received BNT162B2 (Solution for injection), via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization. The patient medical history included unspecified cardiac history. Concomitant medications were not reported. On an unspecified date, the patient experienced some pain in the arm after the first vaccine. The outcome of the event was unknown.    Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Patient bitten by bat 8/8/03 (Rabies positive by testing - bat). Initial rabies series started 8/9/03. Remainder of doses given 8/12, 8/16, 8/23, 8/30 at hospital. Final dose of rabies vaccine given 1 week earlier than recommended. Onset of illness 11/28 with septicemia, multiple abscesses.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 80-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (26 years before the date of reporting). Concomitant products included SHINGRIX. On 21st July 2018, the patient received the 2nd dose of SHINGRIX. On 26th July 2018, 5 days after receiving SHINGRIX, the patient experienced shingles. The patient was treated with acyclovir and prednisone. On an unknown date, the outcome of the shingles was recovering/resolving. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional information was reported as follows: This case was previously reported to the physician. On 14th May 2018, the patient received the 1st dose of SHINGRIX as an concomitant product. The reporter stated that she was diagnosed with shingles on 26th July 2018. The reporter stated that, she felt that the shingles that had come up might had started before she received her 2nd dose, but she further stated that at that time she assumed it was something else, since she had already received the 1st dose of SHINGRIX. The reporter further stated that, the patient experienced shingles on her back, left side and surrounded to the left breast area. The patient further stated that the events experienced by her after the vaccination, were more milder as compared to the shingles acquired by her 26 years ago before the date of reporting.
5 days after MMR vaccine: Temperature increased to 103 degrees. Fine rash on skin.
pt states on the next day 1JUL92 passed out @ 10AM (everything became dark a/passed out), BP was nl; pt says does have high BP; recvt Td 1130AM on 30JUN92;
pt recvd vax; exp sore throat; fever of 101; swollen glands; no rash;
Low fever (around 100.3F); Fatigue; This case was reported by a consumer and described the occurrence of fever in a 11-year-old male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2022-2023 season) (batch number 9249L, expiry date unknown) for prophylaxis.   On 3rd October 2022, the patient received Influenza vaccine Quadrivalent 2022-2023 season. On an unknown date, less than 2 months after receiving Influenza vaccine Quadrivalent 2022-2023 season, the patient experienced fever and fatigue. On an unknown date, the outcome of the fever was not recovered/not resolved and the outcome of the fatigue was unknown.   It was unknown if the reporter considered the fever and fatigue to be related to Influenza vaccine Quadrivalent 2022-2023 season.     Additional Information: GSK Receipt Date: 22-NOV-2022 Reporter's Comment: The patient's parent reported this case. The patient received dose of Quadrivalent Influenza (flu shot) and was experiencing a low fever (around 100.3F) since getting the flu shot.  The fever had persisted for 7 weeks and was still ongoing. The only symptom had been the fatigue. The reporter was writing to ask had GlaxoSmithKline received reports of this side effect (long term low fever), especially for this particular flu shot, was there a way to report this side effect. The reporter also asked did GlaxoSmithKline had a suggestion about the potential treatment. The reporter consented to follow-up.
This is an instance of breakthrough COVID-19 disease after which death occurred.   The individual was vaccinated with the Janssen product on 04/08/2021. They presented to a clinic on 11/15/2021 with symptoms of body aches, cough, and weakness. They tested positive for COVID-19 at this clinic visit. They died on 11/25/2021.
Pt here today for possible allergic reaction to varicella vaccine. vaccine given in left arm 9/19, also had a PPD on the left arm same day, and a MMR vaccine on the right arm the same day. The next afternoon noted soreness at the injection site of the varicella and achiness to enitire left arm and shoulder. Took  800mg of ibuprofen, but did not seem to improve at all. this morning worke up and noticed swelling and redness at the injection site and now entire left arm is throbbing, aching with intermittwnt sharp pains to the shoulder. pain 8/10.  Patient returned to clinic today 9/21 with complaints. Prednisone given to help with imflammation. Pt refused to go to ER or urgent care for imaging,
Received second dose of Pfizer vaccine at 5:29pm on July 14, 2021, at 5:42pm patient began to have facial itching, cough, congestion, nasal itching, facial swelling, facial redness vitals taken BP 144/80, 98 O2 on room air, HR78, RR 22. 50 mg of Diphenhydramine hydrochloride given intramuscular to left deltoid. Patient reported relief of symptoms 7-10 minutes after administration. Vitals at 6:10pm 138/82, 98 Or on room air, HR 71, afebrile, 16 RR.
She got her vaccine, was fine all day.  Went to bed around 11:00 PM and during the night was "out of her mind", having shooting pains throughout her body, little zingers.  She got up the next morning around 8:00 and the zinging pains were all gone except in her left ear and left hip.  The left hip the zinging pains only happened intermittently, 1-2 per hour.  The left ear pain happened about 2 times a minute.  This continued on.  The pain in the left hip went away. The pains in her left ear tended to subside but felt that her head was bigger than it's actually side and just resting on her shoulders, and her left ear did not feel right.  On 4/21/22 she went to the doctor because she felt out of her body.  She checked with another doctor in the clinic who had a subspecialty in Epidemiology who said that he had had a patient with the same symptoms neurological on the same side of the shot and that it was very rare.  Her doctor her that it would be weeks before the symptoms went away.  She has no energy and some "brain fog", hard for her to concentrate and is a highly energetic 82 year old.   She encouraged her to call us.  Her essential tremor on her left side was quite exaggerated and is still more than it's usual way, quite strongly more than it's usual.  She was not given any additional prescriptions.  States that her head just feels heavy but does not have a headache, but takes her medicines on time and if she does not she gets a headache.    Her balance has not been very good, she has to be careful before and now since the vaccine she is extremely careful.  On the 19th she had to use a cane to walk due to the unsteadiness.  This went away in 2-3 hours, but is still not real steady on her feet.    With the 2nd and 3rd  vaccines for 24 hours her joints really ached, and was really tired.  She wasn't herself in that she was foggy in the brain.   Those symptoms lasted 48 hours and she was back to her baseline.
Since being vaccinated, my menstrual cycles have become extremely heavy and irregular. I have passed clots the size of fruit. This past month, I started bleeding on November 5th, and have not stopped. It is November 22nd today. I now have to have my thyroid checked, an ultrasound of my uterus, and a biopsy of my uterus to rule out other issues.
This caused immediate pain in the arm. The pain has continued for the past 20 hours.; This is a spontaneous report from contactable Nurse reporting for herself via Pfizer Sales Representative.  A 48-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot #EJ1685), intramuscular into the right arm on 29Dec2020 11:15 at 0.6 mL, single for COVID-19 immunization. Medical history was none. There were no concomitant medications. The administer cleaned the arm with alcohol but didn't wait for it to dry. On 29Dec2020 the patient experienced immediate pain in the arm. The pain has continued for the past 20 hours. The outcome was recovered.
On Feb. 12th at 2PM symptoms started with lower back pain, pain in abdomen and stomach, cramping, chills, ear ache, pain level 8.  Felt sick all over, like having the flu and then whole body ached, not just GI track.  Left arm injection site was red, sore to touch, swollen (slightly).  Doctor couldn't get vaccination needle into arm muscle the first time and so had to try a second time.   Intense cramping of GI track started up again 8:45AM on Feb. 13th.   By 4PM Feb. 15th fever 102F, chills, felt freezing cold and had to wrap myself in a heating blanket.  Pain level 10, especially in pancreas. Fever broke around 2:30AM Feb. 16th and later when I was up at 8AM I felt very weak, faint, pancreas ached.  Pancreatic pain lasted another 3 days.  Pancreatic pain stayed around level 5.  On Feb. 17th took ibuprophen.  Pain level reduced to 1.   This was the only time that I took pain medication between Feb. 10th and 17th, because I am conservative about using Ibuprophen, Tylenol, and have a high threshold for pain.
Systemic: death (unknown cause)-Severe, Additional Details: Patient was found deceased roughly an hour and a half after receiving Moderna vaccine. He waited 20 minutes at the pharmacy and left however later died. Details are unknown. Sister may have more information.
feels like a mild shingles itching; itching through out the body; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 71-year-old male patient who received Herpes zoster (Shingrix) (batch number PF454, expiry date 26th January 2022) for prophylaxis.   The patient's past medical history included shingles (had 7 to 8 years before the time of reporting). Concurrent medical conditions included enlarged prostate.   On 13th January 2020, the patient received the 2nd dose of Shingrix. On 16th January 2020, 3 days after receiving Shingrix, the patient experienced shingles and generalized pruritus. The patient was treated with prednisone. On an unknown date, the outcome of the shingles and generalized pruritus were recovering/resolving.   It was unknown if the reporter considered the shingles and generalized pruritus to be related to Shingrix.  Additional information was provided as follows: The patient experienced itching throughout the body that travels sometimes worse and sometimes better, which felt like a mild shingles itching. The patient had been to the doctor and was prescribed a course of prednisone and anti histamines at that time. The patient did not take the antihistamines, and his symptoms were remained unrelieved at the time ofreporting. The reporter consented to follow up. The consumer did not know vaccine details for the adverse events. The outcome of the events were reported in source document as recovering and resolving, however it was reported as not recovered and not resolved in database.
This spontaneous report as received from a physician refers to a 14 years old female patient with pertinent medical history and no drug reactions/allergies who on 17-JUL-2012, was vaccinated with the first dose of GARDASIL (route and lot # not reported). No other co-suspects were reported. There was no concomitant medication. It was reported that the patient experienced headache, nausea and vomiting and dizziness on a daily basis, since shortly after the vaccination "approximately in July 2012". The physician reported that the patient was continuing to play sports. The patient did not receive any treatment. The patient contacted the physician. The outcome of headache, dizziness, vomiting and nausea was reported as not recovered/not resolved. The relatedness for headache, dizziness, vomiting and nausea was unknown for GARDASIL. Additional information has been requested.
Systolic pressure for five days up to 220 -  Added extra blood pressure medicine in the middle of the day.  That kept the systolic pressure slightly under 160.  Diastolic pressure was never over 75.  Symptoms were sweating, heart pounding, headache, and fatigue.. Resolved itself on May 16, 2021 at approximately 6 p.m. when blood pressure again registered 125/74.
This spontaneous report as received from a pharmacist refers to a 71 years old female patient with NSAIDs, codeine allergies. The patient was Subcutaneously vaccinated with 0.65 ml ZOSTAVAX (lot # 0566AE exp 01-APR-2013 as reported) on 14-AUG-2012 for vaccination. Pharmacist reported that the patient had been experiencing itching "all over her body" a couple days after receiving ZOSTAVAX. Pharmacist confirmed there was no rash. The patient called pharmacist for medical attention and unspecified steroid cream was given for adverse event. The outcome of itching" all over her body" was reported as not recovered/not resolved. Additional information has been requested.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 14-DEC-2015, the patient received a dose of improperly stored RECOMBIVAX HB lot # L014878, expiration date: 17-JAN-2018 (exact dose, dose number and route of administration were not reported). Concomitant medications were not provided. There were no adverse effects reported. Additional information has been requested.
scarring of the lungs; double pneumonia; cold; flu; exhausted and wiped out; Initial information received on 27-Jan-2021 regarding an unsolicited valid serious case from media via consumer or non-health care professional (Patient).  This case involves adult patient who experienced scarring of the lungs (pulmonary fibrosis), double pneumonia (pneumonia), cold (nasopharyngitis), flu (influenza) and exhausted and wiped out (fatigue), while patient received INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor. Medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number not and expiry date not reported] via n unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious scarring of the lungs (pulmonary fibrosis) and double pneumonia (pneumonia) 5 times then (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  On an unknown date, the patient developed a non-serious cold (nasopharyngitis), flu (influenza) and wiped out (fatigue) unknown latency following the administration of INFLUENZA VACCINE.  It was reported that, a flu shot almost killed patient over 12 years ago. The patient wanted to understand why. Therefore, studied vaccines and was shocked by what patient found. If it were not for the FGDE (Food Grade Diatomaceous Earth) and coffee enemas, patient would not have made it. Anyone who understands that understands the scarring of the lungs and that puts patient in jeopardy for the rest of life. Patient ran out of sick and vacation days so patient went back to work. It took patient a few more months to recovered and was on light duty because patient was completely exhausted and wiped out. It was only by the grace of God patient even survived. Patient had to repent for allowing the pharmaceutical industry to poison patient body. However, it began greatest portion of patient health and wellness journey.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.   It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for events.  Information on the batch number was requested.; Sender's Comments: This case involves adult patient who experienced pulmonary fibrosis, pneumonia, nasopharyngitis, influenza and fatigue after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. There is, however, no information regarding patient's condition at time of vaccination, past history and lab tests do not rule out alternate etiologies, particularly infectious. Based upon the reported information, the role of an individual vaccine cannot be assessed.
This spontaneous report as received from a nurse (Bachelor of Science in Nursing) refers to a 18 month old patient. It was reported that on 22-FEB-2013 the patient was vaccinated with VAQTA (lot # 667534/0415Z, 25/0.5 U/ml, 0.5 ml dose, intramuscular route) that had expired on 13-FEB-2013. No other suspect or concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
Moderate/severe fatigue; muscle discomfort at injection site; muscle discomfort at injection site; This is a spontaneous report from a non-contactable other health professional (patient). A 25-years-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EH9899), intramuscularly on 22Dec2020 08:00 at single dose on left arm for COVID-19 immunization. Medical history included polycystic ovarian syndrome (PCOS), sinus tachycardia, anxiety. Concomitant medication included propranolol, fluoxetine hydrochloride (PROZAC), spironolactone (ALDACTONE A), all from Dec2020. The known allergy included metoclopramide (REGLAN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced moderate/severe fatigue, muscle discomfort at injection site on 23Dec2020 05:45 AM. No treatment received for the adverse events. The events outcome was not recovered. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19. It was not reported as serious.  No follow-up attempts are possible. No further information is expected.
pt awakened on 6/16 with redness, swelling, tenderness, and heat at the injection site pt applied moist heat and swelling went down; still red and tender to touch
About 10-12 days after the second dose of the vaccination I began noticing a persistent foul odor. It is most pronounced when I smell particular food items like coffee and fried food, but it still manifests when there is no food present at all. It has also changed how I perceive my own body odor when I exercise from what I had previously experience to something like a garlic scent.
fever; This is a spontaneous report from a contactable consumer (patient). An 85-year-old patient of an unspecified gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on an unspecified date (at the age of 85-years-old) as dose 1, single for covid-19 immunization. The patient medical history included high blood pressure, earache. Concomitant medications were not reported.  It was reported that, patient called to place a refill for Detrol LA and Skelaxin. Patient stated patient falling apart physically but mentally still there. Patient also stated patient have a trimmer in patient hand. Patient later stated patient have a deteriorating back. Patient also stated patient take three or four (Skelaxin) a day. Patient later stated the last bottle was open and patient don't wanna take any medicine that has been opened. Patient also stated patient got fibromyalgia and Skelaxin is the only thing that helps and Detrol LA. Patient also stated they get cramps when they don't take the medication. Also stated they got a fever when they took the first Pfizer-BioNTech COVID-19 Vaccine. Patient later stated the have high blood pressure and an earache. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Apr2022 as dose 2, single at the age of 51 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Pcos" (unspecified if ongoing), notes: Polycystic ovary syndrome. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results; Positive, notes: Rebound. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: patient received Paxlovid for COVID 19 Treatment. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I originally had swelling and redness but it went down within a couple of days. On day 8 I woke up with a baseball size knot on my atm that was red and running fever.  I received the vaccination at my job, so I went to the nurse and she said to put ice on it and take some benedryll, which I did, and it went away in 2-3 days. The second shot on the second day, gave me a headache, fever, chills, nausea, extremely tired for 3 days.  I rested at home, took aspirin, and felt a little better by 4th day with no fever so I went back to work.
Since the vaccination - have often been breaking out in hives when in extreme heat and sunshine.  Until recently never put the two together that it may have been connected to the Covid vaccination.  Didn't start occurring till the vaccination.  Haven't changed detergent, bath soap, food - or any other lifestyle change.  Saw doctor yesterday who is sending me to an allergist.  See allergist on 27 September 2021.